Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
This study has been completed.
Sponsor:
Gilead Sciences
Collaborator:
Conducted under Salus Pharma, Inc.
Information provided by:
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01055847
First received: January 23, 2010
Last updated: January 25, 2010
Last verified: January 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2004 |
| Primary Completion Date: | August 2004 (Final data collection date for primary outcome measure) |